YKST-03

N/A

Report date: 2026/03/19 17:15:02

Base Information

Drug NameYKST-03
Drug Alias NameYKST-03YKST03
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-Trop-2Anti-CD3
TargetsTumor-associated calcium signal transducer 2T cell surface glycoprotein CD3
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesExcyte Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesExcyte Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A